
C-CAMP and Indegene tie up to help early-stage life sciences startups
The Hindu
The multi-year agreement will see Indegene bring in financial assistance, mentorship via highly skilled and specialised experts, and a digital service suite, supporting C-CAMP’s efforts in nurturing at least 5-7 early-stage deep-science startups with a 360-degree ecosystem.
Centre for Cellular and Molecular Platforms (C-CAMP) and Indegene, a digital-first life sciences commercialisation company, have joined hands to help early-stage life sciences start-ups accelerate technology innovation, product development, and go-to-market.
The multi-year agreement will see Indegene bring in financial assistance, mentorship via highly skilled and specialised experts, and a digital service suite, supporting C-CAMP’s efforts in nurturing at least 5-7 early-stage deep-science startups with a 360-degree ecosystem. This initiative aligns with Indegene’s philosophy of enabling future-ready healthcare globally. The goal of the partnership is to leverage C-CAMP’s incubation programme to strengthen the life sciences innovation ecosystem in India and help bring new drugs and therapies to market faster.

Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.












